Clinical trialNCT04605094TerminatedPhase 2Interventional

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

SponsorAstraZenecaEnrollment194Atopic Dermatitis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Emma Guttman, MD, PhD
MOUNT SINAI HOSPITAL
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Kogarah, Australia
Research Site
Parkville, Australia
Research Site
Sippy Downs, Australia
Research Site
Woolloongabba, Australia

Bulgaria

Research Site
Haskovo, Bulgaria
Research Site
Pleven, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria

Czechia

Research Site
Brno, Czechia
Research Site
Ostrava, Czechia
Research Site
Ostrava-Poruba, Czechia
Research Site
Pardubice, Czechia
Research Site
Prague, Czechia
Research Site
Prague, Czechia

France

Research Site
Brest, France
Research Site
Lille, France

Poland

Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Osielsko, Poland
Research Site
Poznan, Poland
Research Site
Warsaw, Poland

South Korea

Research Site
Ansan-si, South Korea
Research Site
Daegu, South Korea
Research Site
Gwangju, South Korea
Research Site
Seongnam-si, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Yangsan, South Korea

Spain

Research Site
Alicante, Spain
Research Site
Barcelona, Spain
Research Site
Córdoba, Spain
Research Site
Madrid, Spain
Research Site
Manises, Spain

United States

Research Site
Los Angeles, California, United States
Research Site
Newport Beach, California, United States

11 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Nov 2020
Primary completion: 25 Apr 2022
Completion: 13 Sept 2022
Last update posted: 31 Aug 2023
Registered enrollment: 194
Registry id: NCT04605094

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.